Skip to main content

C-RAD AB: First orders to South Korea

Press release 2011-12-02

Press release 2011-12-02

 

First orders of the C-RAD Catalyst™ to South Korea

C-RAD AB with its four fully owned subsidiaries are all active in the field of radiation therapy. The C-RAD representative HDX Corporation in South Korea has placed an order of one Sentinel and two Catalyst systems. The installed systems will mainly be used for so called free breathing gating.

With the introduction of the Catalyst™ system C-RAD has launched a unique solution for free breathing gating. Together with the Sentinel™ system for gated computed tomography a solution with superior performance can be offered to the radiation therapy clinics. The Catalyst™ system can in parallel control the respiratory gating process and monitor overall patient motion during treatment delivery.

The new Catalyst™ system and the previously launched Sentinel™ system form a complete product offering and tailored configurations can be offered based on customer requests. With this product portfolio is C-RAD the world leading company to offer optical surface tracking and monitoring systems for enhanced precision, patient safety and efficiency in advanced radiation therapy.  

With the new order HDX Corporation has in total placed orders of nine systems. Four of the systems have in between been installed. Conditions for these orders are working interfaces to Varian linacs. The so called MMI interface for communication between the Catalyst system and Varian linacs is since last November included in the Varian price book.

Erik Hedlund, CEO, C-RAD AB:

”South Korea has become one of the major markets for the C-RAD optical surface tracking solutions.HDX Corporation has placed orders of totally nine systems. HDX is in the country the dominant vendor in radiation therapy.

C-RAD has experienced a fast growing demand for systems with respiratory gating both with free breathing and breath hold. The objective is to reduce dose to the cardiac tissue. The immediate response by larger clinics is encouraging. Important is the availability of working interfaces to Varian linacs."

 

For further information:

Erik Hedlund, CEO C-RAD AB, Phone +46-(0)18-66 69 31, E-Mail erik.hedlund@c-rad.se

 

 

 

Close Menu